|

EBV-TCR-T cells Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 2

Top Sponsors

  • Chinese PLA General Hospital2

Indications

  • Cancer2
  • EBV-associated Hemophagocytic Lymphohistiocytosis1
  • EBV Infection After Allogenic HSCT1
  • EBV Infection1

Other2 trials

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT
Phase 1
Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.